When your pharmaceutical company is working on a new project to develop new medicines, in this scenario, all they need is to take help from the pharmaceutical regulatory consulting company so that the project cannot face any burdens at thi…

If you don’t know, the development process of new drugs is not as easy as it may sound. Most pharmaceutical companies can take between 12 and 15 years from starting to research an active ingredient until it is available to patients. It is …

Today we are going to tell you about the advantages of choosing professional Regulatory affairs services to regularize and host your products. Exporting your products can be a great growth opportunity. The geo-political demand created a fa…

On November 22, 2017, EMA launches a “new and improved” version of EudraVigilance (analogous to FDA Medwatch program). The result will be a total transition in the way that Individual case safety reports (ICSRs) are tracked and reported th…